241 related articles for article (PubMed ID: 9654190)
1. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
Kunze E; Schulz H; Gabius HJ
J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
[TBL] [Abstract][Full Text] [Related]
2. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
3. Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats.
Kunze E; Schulz H; Ahrens H; Gabius HJ
Exp Toxicol Pathol; 1997 Aug; 49(3-4):167-80. PubMed ID: 9314050
[TBL] [Abstract][Full Text] [Related]
4. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R
Nat Immun; 1996-1997; 15(6):295-311. PubMed ID: 9523281
[TBL] [Abstract][Full Text] [Related]
5. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model.
Elsässer-Beile U; Ruhnau T; Freudenberg N; Wetterauer U; Mengs U
Cancer; 2001 Mar; 91(5):998-1004. PubMed ID: 11251952
[TBL] [Abstract][Full Text] [Related]
6. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
Hajto T; Hostanska K; Weber K; Zinke H; Fischer J; Mengs U; Lentzen H; Saller R
Nat Immun; 1998; 16(1):34-46. PubMed ID: 9789123
[TBL] [Abstract][Full Text] [Related]
7. [Mistletoe therapy from the pharmacologic perspective].
Hajto T; Hostanska K; Saller R
Forsch Komplementarmed; 1999 Aug; 6(4):186-94. PubMed ID: 10529578
[TBL] [Abstract][Full Text] [Related]
8. Selective modulation of phosphatidylserine exposure on subpopulations of human peripheral blood lymphocytes by a plant lectin, Viscum album agglutinin (VAA)-I and its recombinant form (rVAA) in vitro.
Hostanska K; Hajto T; Fischer J; Mengs U; Weber K; Lentzen H; Saller R
Cancer Detect Prev; 1999; 23(6):511-23. PubMed ID: 10571662
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of immunoactive mistletoe lectin-I.
Beuth J
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
[TBL] [Abstract][Full Text] [Related]
10. Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells.
Kim MS; So HS; Lee KM; Park JS; Lee JH; Moon SK; Ryu DG; Chung SY; Jung BH; Kim YK; Moon G; Park R
Gen Pharmacol; 2000 May; 34(5):349-55. PubMed ID: 11368891
[TBL] [Abstract][Full Text] [Related]
11. Galactoside-specific plant lectin, Viscum album agglutinin-I induces enhanced proliferation and apoptosis of murine thymocytes in vivo.
Hajtó T; Berki T; Boldizsár F; Németh P
Immunol Lett; 2003 Mar; 86(1):23-7. PubMed ID: 12600741
[TBL] [Abstract][Full Text] [Related]
12. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
Beuth J; Ko HL; Tunggal L; Steuer MK; Geisel J; Jeljaszewicz J; Pulverer G
In Vivo; 1993; 7(5):407-10. PubMed ID: 8110981
[TBL] [Abstract][Full Text] [Related]
13. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
Büssing A; Suzart K; Schweizer K
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S9-14. PubMed ID: 9179360
[TBL] [Abstract][Full Text] [Related]
14. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
15. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
[TBL] [Abstract][Full Text] [Related]
16. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
Hajto T; Hostanska K; Gabius HJ
Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
[TBL] [Abstract][Full Text] [Related]
17. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
Stein GM; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
[TBL] [Abstract][Full Text] [Related]
18. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro.
Stein GM; Edlund U; Pfüller U; Büssing A; Schietzel M
Anticancer Res; 1999; 19(5B):3907-14. PubMed ID: 10628330
[TBL] [Abstract][Full Text] [Related]
19. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
In Vivo; 1994; 8(6):989-92. PubMed ID: 7772751
[TBL] [Abstract][Full Text] [Related]
20. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]